Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis
- 31 March 2012
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 142 (3), 442-452.e5
- https://doi.org/10.1053/j.gastro.2011.11.019
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2010
- Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis From the International BEACON ConsortiumJNCI Journal of the National Cancer Institute, 2010
- Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's EsophagusGastroenterology, 2010
- Medication Usage and the Risk of Neoplasia in Patients With Barrett's EsophagusClinical Gastroenterology and Hepatology, 2009
- Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005British Journal of Cancer, 2009
- Nonsteroidal Antiinflammatory Drugs and Risk of Gastric Adenocarcinoma: The Multiethnic Cohort StudyAmerican Journal of Epidemiology, 2009
- Trends in incidence of oesophageal and stomach cancer subtypes in EuropeEuropean Journal of Gastroenterology & Hepatology, 2009
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysisBritish Journal of Cancer, 2009
- Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter–Relaxing Drugs and Risk of Esophageal and Gastric CancersClinical Gastroenterology and Hepatology, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003